NEW ALS RESEARCH PLANNED The world’s most famous sufferer of amyotrophic lateral sclerosis (ALS), and possibly the smartest man in the world, physicist Stephen Hawking. Oxford BioDynamics has announced its Malaysian subsidiary will lead research that may drastically reduce the diagnosis time for the crippling fatal disease. AFP PHOTO
UK-based biotechnology company Oxford BioDynamics will conduct research to develop a better diagnostic test for the crippling disease amyotrophic lateral sclerosis (ALS) through its subsidiary in Penang, Malaysia, the company announced in a statement.